Improved clinical outcomes of tocilizumab versus cyclophosphamide for IgG4-related disease: insights from a prospective IgG4-related disease registry

OBJECTIVE: To compare the clinical outcomes of patients with active immunoglobulin G (IgG) 4 related disease (IgG4-RD) receiving tocilizumab versus those receiving cyclophosphamide (CYC). METHODS: This IgG4-RD registry study was a prospective cohort study conducted among patients with active IgG4-RD...

Descripción completa

Detalles Bibliográficos
Autores principales: Zongfei, Ji, Lijuan, Zhang, Ying, Sun, Dongmei, Liu, Sifan, Wu, Xiufang, Kong, Lingying, Ma, Yun, Liu, Lili, Ma, Huiyong, Chen, Lindi, Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252355/
https://www.ncbi.nlm.nih.gov/pubmed/34262681
http://dx.doi.org/10.1177/20406223211028776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252355/
https://www.ncbi.nlm.nih.gov/pubmed/34262681
http://dx.doi.org/10.1177/20406223211028776

Ejemplares similares